EGFR and cancer: GE11 surface modification significantly enhanced the cellular uptake of Se NPs through EGFR-mediated endocytosis in EGFR over-expressed cancer cells, which resulted in enhanced inhibition effects against cancer cells and reduced toxicity against normal cells of GE11-Ori-Se NPs.